Market revenue in 2022 | USD 16,128.6 million |
Market revenue in 2030 | USD 24,352.4 million |
Growth rate | 5.3% (CAGR from 2022 to 2030) |
Largest segment | Dietary supplements |
Fastest growing segment | Dietary Supplements |
Historical data covered | 2018 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | OTC pharma products, Dietary Supplements |
Dietary supplements was the largest segment with a revenue share of 95.18% in 2024. Horizon Databook has segmented the Global menopause market based on otc pharma products, dietary supplements covering the revenue growth of each sub-segment from 2018 to 2030.
By 2025, over 1 billion women globally are anticipated to reach menopause, which would make up approximately 12% of the global population. Vasomotor symptoms are experienced by almost 75% of women undergoing menopause. This can lead to an overall loss of productivity and quality of life, making treatment crucial.
This creates a wide population pool to be served by menopause products, such as dietary supplements and over-the-counter drugs that can help relieve symptoms including hot flashes, osteoporosis, night sweats, & vaginal atrophy. Furthermore, early treatment can reduce stress of high healthcare expenditure, as women facing vasomotor symptoms lead to an overall burden of USD 660 million globally.
In addition, productivity loss accounts for additional USD 150 million. Menopause also triggers other healthcare conditions in women, such as reduced musculoskeletal health and increased risk of cardiovascular diseases.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account